Skip to main content
QXL Diagnostics
P1 Specialized SerologyInvestigation & AssayNABL Accredited Lab (MC-6849)

Syphilis Testing in Bangalore: RPR Titers & TPHA Confirmation

Comprehensive dual-algorithm serology for Treponema pallidum. Differentiating active primary/secondary syphilis, latent disease, and successful past treatment response.

Clinical Overview

Evidence-Based Understanding & Diagnostic Protocol

Syphilis, caused by the spirochete Treponema pallidum, is known as the 'Great Imitator' due to its diverse clinical presentations spanning primary ulcers, secondary rashes, and years of asymptomatic latency.

Accurate diagnosis requires two complementary classes of serological tests: Non-Treponemal tests (like Rapid Plasma Reagin / RPR or VDRL) and Treponemal tests (like TPHA or Treponema pallidum ECLIA).

Non-treponemal tests measure reaginic antibodies and provide a quantitative titer (e.g., 1:16, 1:64) that correlates with disease activity and falls after successful penicillin treatment. Treponemal tests measure specific antibodies to the organism and typically remain positive for life, confirming past exposure.

Key Clinical Takeaways

  • Both a non-treponemal (RPR) and treponemal (TPHA) test are required for accurate diagnosis.
  • Quantitative RPR titers monitor active infection and confirm successful cure after penicillin therapy.
  • TPHA remains positive for life in most patients even after complete antibiotic cure.
  • Syphilis antibodies typically become detectable 3 to 6 weeks after exposure.
Recommended Investigations

Available Laboratory Assays & Pricing

NABL-accredited diagnostic investigations performed under strict ISO 15189:2022 standards.

Investigation / AssaySpecimen TypeWindow / TimingTurnaround TimePrice (₹)
Syphilis Dual Screening & Confirmation (RPR + TPHA)
Includes quantitative RPR titer and definitive TPHA hemagglutination.
Venous Blood (Serum)3–6 Weeks12–24 Hours₹750
Quantitative RPR with Reflex Titration
Reports exact endpoint dilution ratio for clinical treatment monitoring.
Venous Blood (Serum)3–6 Weeks6–12 Hours₹450
Treponema pallidum Total Antibodies (CLIA)
Automated high-sensitivity chemiluminescence treponemal screen.
Venous Blood2–4 Weeks6 Hours₹650
Strict Confidentiality & Laboratory Governance

Physical Central Facilities in Bengaluru

Samples are processed directly at our NABL-accredited reference laboratory facilities in Kengeri and Yelahanka, operating under ISO 15189:2022 standards (Certificate No. MC-6849). No third-party outsourcing.

Kengeri Hub: 540, 1st Floor, 5th Cross, Kengeri Satellite Town, Bengaluru 560060
Yelahanka Facility: North Bengaluru Referral Centre, Yelahanka, Bengaluru 560064

100% Discrete Patient Privacy Guarantee

  • Numeric Barcoding: Laboratory samples are processed via alphanumeric barcodes without patient names on testing tubes.
  • Encrypted Digital PDF: Password-protected lab reports delivered exclusively to your private WhatsApp or email.
  • Discreet Phlebotomy: Trained phlebotomy specialists available in plain clothes with temperature-controlled cold chain.
Frequently Asked Questions

Direct Questions & Clinical Answers

Clear, transparent answers designed for patient clarity and AI-assisted search retrieval.

Why does a syphilis test have two different parts (RPR and TPHA)?▼
RPR is non-specific and can have biological false positives (from autoimmune conditions or pregnancy). TPHA is highly specific to Treponema pallidum. Performing both confirms true infection and indicates whether it is active or past-treated.
What does a titer like 1:16 mean?▼
A titer measures how much your blood can be diluted and still show reactivity. Higher titers (like 1:16, 1:32, or 1:64) indicate active or recent infection. Successful treatment is confirmed when the titer drops by at least fourfold (e.g., from 1:16 down to 1:4).
Can syphilis be cured?▼
Yes. Syphilis is completely curable with appropriate penicillin injections (or doxycycline if penicillin-allergic). However, treatment does not reverse permanent late-stage tissue damage, making early diagnosis critical.

Clinical Evidence & Guideline References

Related Sexual Health Topics & Investigations

Clinically Reviewed by Dr. Shantakumar Muruda, MD (Biochemistry)Consultant Clinical Biochemist, Founder & CEO – QXL Diagnostics, NABL Lead & Technical Assessor
NABL Accredited (MC-6849)Updated: November 19, 2026
Clinical Reference Standards:Content developed in alignment with Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th Edition, Chapters 2, 11, and 20), CDC Sexually Transmitted Infections Treatment Guidelines, World Health Organization (WHO) Post-Exposure Prophylaxis (PEP) protocols, and NACO HIV diagnostic algorithms.
Patient Privacy & Specimen Safety:All sexual health investigations adhere to strict confidential diagnostic protocols. Doorstep sample collection is conducted by trained phlebotomy specialists in unmarked packaging. Digital reports are encrypted and delivered directly to the patient with optional anonymous barcode reporting.